SCHEMBL6949199

SCHEMBL6949199

CC(C)(C)OC(=O)NCCCCCCCCNC(=NC#N)Nc1ccncc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.46
CYP17A1 P05093 2/20 0.46
CYP3A4 P08684 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
CSNK2A2 P19784 1/20 0.43
CSNK2A1 P68400 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
KEAP1 Q14145 2/20 0.41
NFE2L2 Q16236 2/20 0.41
LATS1 O95835 2/20 0.41
NR1H4 Q96RI1 1/20 0.41
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
FPR3 P25089 1/20 0.40
FPR2 P25090 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL810259 1.00 IKBKB (0.46) IKBKBCYP17A1CYP3A4TDP1CSNK2A2
SCHEMBL2672274 0.83 NAMPT (0.55) CYP3A4KEAP1NFE2L2NR1H4NPSR1
SCHEMBL20095479 0.81 IKBKB (0.50) IKBKBCYP3A4KEAP1NFE2L2MAPT
SCHEMBL7098728 0.81 CYP1A2 (0.53) IKBKBKEAP1NFE2L2LATS1KDM4E
SCHEMBL20095475 0.81 CYP1A2 (0.53) IKBKBKEAP1NFE2L2LATS1KDM4E
SCHEMBL31203373 0.79 CA1 (0.61) CYP17A1CYP3A4TDP1CA1CA2
SCHEMBL6949196 0.78 CYP3A4 (0.44) CYP17A1CYP3A4TDP1CSNK2A2CSNK2A1
SCHEMBL7262254 0.78 CYP3A4 (0.44) CYP17A1CYP3A4TDP1CSNK2A2CSNK2A1
SCHEMBL504843 0.78 CYP3A4 (0.44) CYP17A1CYP3A4TDP1CSNK2A2CSNK2A1
SCHEMBL504842 0.78 CYP3A4 (0.44) CYP17A1CYP3A4TDP1CSNK2A2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0984936-B1 CYANOGUANIDINES AS CELL PROLIFERATION INHIBITORS LEO PHARMA AS WITH SECONDARY N (DK) 2003-09-03 EP claimed